GUILFORD, Conn.–(BUSINESS WIRE)– May 09, 2022–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing single molecule protein sequencing, today announced the appointment of Patrick Schneider, Ph.D., as President and Chief Operating Officer (COO). Schneider will succeed Michael McKenna, Ph.D., who will remain as Executive Vice President, Product Development and Operations. “We have […]

GUILFORD, Conn.–(BUSINESS WIRE)– Apr. 18, 2022–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing single molecule protein sequencing, today announced that it will report financial results for the first quarter 2022 after market close on Monday, May 9, 2022. Company management will host a conference call to discuss financial results and provide […]

GUILFORD, Conn.–(BUSINESS WIRE)– Mar. 28, 2022–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing single molecule protein sequencing, today announced that it will be participating in the B. Riley Disruptive Biotech Enabling Technologies Virtual Mini Conference. Quantum-Si’s management is scheduled to present virtually on Thursday, April 7, 2022 at 10:20 am ET. […]

GUILFORD, Conn.–(BUSINESS WIRE)– Feb. 28, 2022–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing single molecule protein sequencing, today announced financial results for the fourth quarter and fiscal year ended December 31, 2021. Recent Business Highlights Announced the appointment of Dr. Jonathan Rothberg, Founder and Executive Chairman of the Board, as Interim […]

GUILFORD, Conn.–(BUSINESS WIRE)– February 18, 2022–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences tools company commercializing single molecule protein sequencing, today announced that it will be participating virtually in the 42nd Annual Cowen Health Care Conference. Quantum-Si’s management is scheduled to present virtually on Tuesday, March 8, 2022 at 2:10 pm ET. A live […]

Founder and Executive Chairman of the Board to Advance Quantum-Si’s Protein Sequencing Technology and Commercialization Strategy GUILFORD, Conn.–(BUSINESS WIRE)– Feb. 14, 2022–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing single molecule protein sequencing, today announced the appointment of Dr. Jonathan Rothberg, Founder and Executive Chairman of Quantum Si’s Board of Directors, […]

GUILFORD, Conn.–(BUSINESS WIRE)– Feb. 07, 2022 — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si” or the “Company”), a life sciences tools company commercializing a single molecule protein sequencing platform, today announced that it will report fourth quarter and full year 2021 financial results after market close on Monday, February 28, 2022. Company management will host a conference call on the […]

GUILFORD, Conn.–(BUSINESS WIRE)– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si” or the “Company”), a life sciences tools company commercializing a unique protein sequencing platform, today announced that it will participate in the 40th Annual J.P. Morgan Healthcare Conference to be held virtually on January 10-13, 2022. Quantum-Si’s management is scheduled to present virtually on Wednesday, January 12, 2022 at […]

GUILFORD, Conn.–(BUSINESS WIRE)– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences tools company commercializing a unique protein sequencing platform, today announced that it has been added to the Nasdaq Biotechnology Index (Nasdaq: NBI). The addition is based on the results of the annual reconstitution of the index announced by Nasdaq on December 10, […]

Quantum-Si Continues Momentum and Accelerates Commercialization Efforts GUILFORD, Conn., November 10. Quantum-Si Incorporated (NASDAQ: QSI) (“Quantum-Si” or the “Company”), a life sciences tools company commercializing a unique protein sequencing platform, today announced financial results for the quarter ended September 30, 2021 and provided a business update. Recent Highlights Expanded Early Access program to ten, with […]